The Biological Safety Testing Market size is expected to grow at an annual average of 11% during 2021-2027. Biological safety testing refers to bioanalytical testing performed by pharmaceutical and biotechnology companies or contract research institutes in the pharmaceutical manufacturing/packaging sector and may include several disciplines such as pharmacology, toxicology, microbiology, etc. These testing procedures mainly focus on the safety of materials from the raw material stage, from intermediate to final product.
A full report of Biological Safety Testing Market available at: https://www.orionmarketreports.com/biological-safety-testing-market/11466/
Company Profile
• Eurofins Scientific
• Lonza
• Merck KGaA
• Promega Corporation
• Thermo Fisher Scientific
Biological Safety Testing Market- Segmentation
By Product & Services
• Consumables
• Instrument
• Services
By Application
• Vaccine Manufacturing
• Monoclonal Antibodies Manufacturing
• Cellular & Gene Therapy Products Manufacturing
• Blood and Blood Products Manufacturing
• Other Application
By Test Type
• Endotoxin Test
• Sterility Test
• Mycoplasma Tests
• Bioburden Tests
• Residual Host-Cell Proteins & DNA Detection Tests
• Virus Safety Test
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
